Literature DB >> 15655836

Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma.

Hong-Bing Ma1, Hai-Tao Hu, Zheng-Li Di, Zuo-Ren Wang, Jing-Sen Shi, Xi-Jing Wang, Yi Li.   

Abstract

AIM: To investigate the role of cyclin D1, p16 and retinoblastoma in cancerous process of gallbladder carcinomas and to assess the relation between cyclin D1, p16, Rb and the biological characteristics of gallbladder carcinoma.
METHODS: Forty-one gallbladder carcinoma, 7 gallbladder adenoma and 14 chronic cholecystitis specimens were immunohistochemically and histopathologically investigated for the relation of cyclin D1, p16 and Rb with Nevin staging and pathologic grading.
RESULTS: The expression rates of abnormal cyclin D1 in gallbladder carcinoma (68.3%) and gallbladder adenoma (57.1%) were significantly higher than those in chronic cholecystitis (7.1%) (P<0.05). No significant difference was found both among the pathological grades G(1), G(2) and G(3) and among Nevin stagings S(1)-S(2), S(3) and S(4)-S(5) of gallbladder carcinoma. The positive rates of p16 (48.8%) and Rb (58.5%) in gallbladder carcinoma were significantly lower compared to those in adenoma (100.0%) and cholecystitis (100.0%) (P<0.05). The positive rates of p16 and Rb in Nevin stagings S(1)-S(2) (80.0% and 90.0%) and S(3) (46.2% and 61.5%) gallbladder carcinomas were significantly higher than those in S(4)-S(5) (33.3% and 38.8%) (P<0.05), and those in pathologic grades G(1) (54.5% and 81.8%) and G(2) (50.0% and 62.5%) gallbladder carcinoma were significantly higher than those in G(3) (28.6% and 35.7%) (P<0.05). The protein expression of p16 and Rb had a negative-correlation in gallbladder carcinoma (r = -0.2993, P<0.05), and this negative-correlation was correlated with Nevin staging (P<0.05). Moreover, the protein expression of p16 and cyclin D1 had a negative-correlation in gallbladder carcinoma (r = -0.9417, P<0.05).
CONCLUSION: Cyclin D1 may play a role in the early stage of gallbladder carcinoma. Mutation of p16 and Rb genes might be correlated with progression of gallbladder carcinoma. Analysis of p16 and Rb can estimate the prognosis of gallbladder carcinoma. Expression of p16 and Rb may be correlated with Nevin staging and pathologic grading in gallbladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655836      PMCID: PMC4250753          DOI: 10.3748/wjg.v11.i5.744

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.

Authors:  Berthold Gerdes; Annette Ramaswamy; Andreas Ziegler; Sven A Lang; Michael Kersting; Renate Baumann; Anja Wild; Roland Moll; Matthias Rothmund; Detlef K Bartsch
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.

Authors:  Gloria Peiró; Joachim Diebold; Udo Löhrs
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

Review 3.  Molecular targeting and pharmacogenomics in the management of advanced bladder cancer.

Authors:  Derek Raghavan
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

4.  Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Authors:  H Azechi; N Nishida; Y Fukuda; T Nishimura; M Minata; H Katsuma; M Kuno; T Ito; T Komeda; R Kita; R Takahashi; K Nakao
Journal:  Oncology       Date:  2001       Impact factor: 2.935

5.  Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas.

Authors:  Y Z Shi; A M Hui; X Li; T Takayama; M Makuuchi
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

6.  Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.

Authors:  Y Ito; N Matsuura; M Sakon; E Miyoshi; K Noda; T Takeda; K Umeshita; H Nagano; S Nakamori; K Dono; M Tsujimoto; M Nakahara; K Nakao; N Taniguchi; M Monden
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

7.  Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.

Authors:  Enrique Lerma; Manel Esteller; James G Herman; Jaime Prat
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

Review 8.  Cyclin D-dependent kinases, INK4 inhibitors and cancer.

Authors:  Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Biochim Biophys Acta       Date:  2002-03-14

Review 9.  [Research advances on bladder cancer associated genes].

Authors:  Rui Zhang; Jian-Jun Zhang; Zu-Gen He; Shu-Jun Cheng; Yan-Ning Gao
Journal:  Ai Zheng       Date:  2003-01

10.  Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.

Authors:  Roger M Feakins; Carole D Nickols; Heena Bidd; Sarah-Jane Walton
Journal:  Hum Pathol       Date:  2003-12       Impact factor: 3.466

View more
  5 in total

1.  Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma.

Authors:  Bo Liu; Yangde Zhang; Mingmei Liao; Zhansheng Deng; Liansheng Gong; Jiarui Jiang; Ling Lynn; Kai Wu; Xiongying Miao
Journal:  Pathol Oncol Res       Date:  2010-06-22       Impact factor: 3.201

2.  ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients.

Authors:  Kai Wu; Mingmei Liao; Bo Liu; Zhansheng Deng
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

3.  Two distinct pathways of p16 gene inactivation in gallbladder cancer.

Authors:  Hiroyuki Tadokoro; Takako Shigihara; Tomomi Ikeda; Masaru Takase; Masafumi Suyama
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

Review 4.  Molecular Oncology of Gall Bladder Cancer.

Authors:  Arun Chaturvedi; Vijay Kumar; Sameer Gupta
Journal:  Indian J Surg Oncol       Date:  2019-11-16

Review 5.  Gallbladder Cancer in the 21st Century.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Shahid Ahmed; Selliah Chandra Kanthan
Journal:  J Oncol       Date:  2015-09-01       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.